State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Chongqing Key Laboratory of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Int J Hyperthermia. 2023;40(1):2202372. doi: 10.1080/02656736.2023.2202372.
OBJECTIVE: To investigate the histopathological findings and follow-up outcome of focused ultrasound ablation surgery (FUAS) treatment of multiple fibroadenomas (FA). METHODS: A total of 20 patients with 101 multiple FAs were enrolled. After one session FUAS ablation, 21 lesions (≥15.0 mm) were surgically removed within one week for histopathological analysis, including 2, 3, 5-triphenyltetrazolium chloride (TTC) staining, H&E staining, nicotinamide adenine dinucleotide (NADH) -flavretin enzyme staining, Transmission electron microscope (TEM) and scanning electron microscope (SEM). The remaining 80 lesions were followed up at 3, 6 and 12 months after treatment. RESULTS: All ablation procedures were performed successfully. Pathologic findings showed that irreversible damage of FA was confirmed. TTC, H&E and NADH staining and TEM/SEM demonstrated tumor cell death and tumor structural destruction at the gross, cellular, and subcellular levels, respectively. The median shrinkage rate at 12 months post-FUAS was 66.4 (43.6, 89.5) %. CONCLUSION: Histopathological analysis for FAs after FUAS treatment proved that FUAS could effectively induce irreversible coagulative necrosis of FA, and the tumor volume would gradually shrink in follow-up. FUAS was safe and effective to treat multiple FAs with good cosmesis.Key pointsThis study was the first study of detailed histopathological analysis for FAs after FUAS treatment.FUAS can effectively induce irreversible coagulative necrosis of fibroadenoma cells.FUAS ablation of multiple fibroadenomas is safe and effective.
目的:研究聚焦超声消融术(FUAS)治疗多发性纤维腺瘤(FA)的组织病理学发现和随访结果。
方法:共纳入 20 例 101 个多发性 FA 患者。FUAS 消融治疗 1 次后,1 周内行 21 个(≥15.0mm)病灶切除术,行 2,3,5-三苯基氯化四氮唑(TTC)染色、苏木精-伊红(H&E)染色、烟酰胺腺嘌呤二核苷酸(NADH)-黄递酶染色、透射电镜(TEM)和扫描电镜(SEM)组织学检查,分析组织病理学变化。其余 80 个病灶在治疗后 3、6 和 12 个月进行随访。
结果:所有消融手术均顺利完成。病理结果证实 FA 不可逆损伤。TTC、H&E 和 NADH 染色以及 TEM/SEM 分别从大体、细胞和亚细胞水平显示肿瘤细胞死亡和肿瘤结构破坏。FUAS 治疗后 12 个月的平均体积缩小率为 66.4%(43.6%,89.5%)。
结论:FUAS 治疗后 FA 的组织病理学分析证实 FUAS 能有效诱导 FA 不可逆性凝固性坏死,且肿瘤体积在随访中逐渐缩小。FUAS 治疗多发性 FA 安全有效,美容效果良好。
关键点:本研究为首例 FUAS 治疗后 FA 的详细组织病理学分析研究。FUAS 可有效诱导纤维腺瘤细胞发生不可逆性凝固性坏死。FUAS 消融治疗多发性纤维腺瘤安全有效。
Zhonghua Fu Chan Ke Za Zhi. 2022-4-25
Zhonghua Fu Chan Ke Za Zhi. 2024-3-25
Am J Surg. 2006-10
Zhonghua Fu Chan Ke Za Zhi. 2022-4-25
Eur J Obstet Gynecol Reprod Biol. 2021-3
Am J Surg. 2002-11
Am J Transl Res. 2023-12-15